Skip to main content

A Phase IB/II Multi-Cohort Study of Targeted Agents with Atezolizumab for Patients with Recurrent or Persistent Endometrial Cancer

Research Grant
Duke Scholars

Administered By

Medicine, Medical Oncology

Awarded By

Alliance Foundation Trials, LLC

Start Date

September 1, 2021

End Date

August 31, 2024
 

Administered By

Medicine, Medical Oncology

Awarded By

Alliance Foundation Trials, LLC

Start Date

September 1, 2021

End Date

August 31, 2024